IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY24 results · Apr–Jun 2023
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹563.18 crore (down 0.3% from Q1 FY23) and net profit of ₹45.86 crore (up 32.3% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 563.18 | 565.01 | −0.3% | 587.21 | −4.1% |
| Other income | 7.06 | 5.16 | +36.8% | 8.73 | −19.1% |
| Total income | 570.24 | 570.17 | +0.0% | 595.94 | −4.3% |
| Profit before tax | 61.18 | 46.59 | +31.3% | 87.04 | −29.7% |
| Net profit for the period | 45.86 | 34.67 | +32.3% | 64.78 | −29.2% |
| EPS, basic (₹) | 7.81 | 5.91 | +32.1% | 11.03 | −29.2% |
| Net margin (%) | 8.1 | 6.1 | 11.0 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 563.18 | 565.01 | −0.3% | 587.21 | −4.1% |
| Other income | 7.06 | 5.15 | +37.1% | 8.72 | −19.0% |
| Total income | 570.24 | 570.16 | +0.0% | 595.93 | −4.3% |
| Profit before tax | 61.53 | 46.81 | +31.4% | 87.53 | −29.7% |
| Net profit for the period | 46.21 | 34.89 | +32.4% | 65.27 | −29.2% |
| EPS, basic (₹) | 7.87 | 5.94 | +32.5% | 11.11 | −29.2% |
| Net margin (%) | 8.2 | 6.2 | 11.1 |
Consolidated
- Filed with BSE
- 09 Aug 2023, 18:45 IST
- Board meeting
- 09 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 09 Aug 2023, 18:45 IST
- Board meeting
- 09 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Audited
- Source
- XBRL filing on BSE